Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.41 |
| ▸ | ACHE | P22303 | 3/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1054610 | 0.85 | TSHR (0.50) | TSHRACHENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL988670 | 0.81 | ESR1 (0.46) | TSHRACHEESR1ESR2NPC1 | |
| SCHEMBL8575049 | 0.79 | TSHR (0.39) | TSHRACHEESR1ESR2NPC1 | |
| SCHEMBL11349968 | 0.79 | TSHR (0.39) | TSHRACHEESR1ESR2NPC1 | |
| SCHEMBL29431181 | 0.78 | TSHR (0.43) | TSHRACHEESR1ESR2NPC1 | |
| SCHEMBL1960743 | 0.78 | TSHR (0.43) | TSHRACHEESR1ESR2NPC1 | |
| SCHEMBL987142 | 0.78 | TSHR (0.43) | TSHRACHEESR1ESR2NPC1 | |
| SCHEMBL2453376 | 0.78 | TSHR (0.43) | TSHRACHEESR1ESR2NPC1 | |
| SCHEMBL1315056 | 0.77 | TSHR (0.38) | TSHRACHEESR1ESR2NPC1 | |
| SCHEMBL12815469 | 0.77 | ESR1 (0.30) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11177446-B2 | Silicon containing organic fluorescent materials | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-11-16 | — | — | US | disclosed |
| US-20190081253-A1 | SILICON CONTAINING ORGANIC FLUORESCENT MATERIALS | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2019-03-14 | — | — | US | disclosed |
| US-9926383-B2 | Biocompatible three dimensional matrix for the immobilization of biological substances | LEUKOCARE AG (DE) | 2018-03-27 | — | — | US | disclosed |
| WO-2013081080-A1 | METHOD FOR PRODUCING OLEFIN BLOCK POLYMER USING PLURALITY OF TYPES OF TRANSITION METAL CATALYSTS | 住友化学株式会社 (JP) | 2013-06-06 | — | — | WO | disclosed |
| EP-2021374-B1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | LEUKOCARE AG (DE) | 2011-09-21 | — | — | EP | disclosed |
| US-20100291665-A1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | LEUKOCARE AG (DE) | 2010-11-18 | — | — | US | disclosed |
| US-20090269778-A1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | LEUKOCARE AG (DE) | 2009-10-29 | — | — | US | disclosed |
| WO-2009059784-A1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | LEUKOCARE AG (DE) | 2009-05-14 | — | — | WO | disclosed |
| EP-2058335-A1 | Biocompatible three dimensional matrix for the immobilization of biological substances | Leukocare AG (DE) | 2009-05-13 | — | — | EP | disclosed |
| EP-2021374-A1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | Leukocare AG (DE) | 2009-02-11 | — | — | EP | disclosed |
| WO-2007128550-A1 | BIOCOMPATIBLE THREE DIMENSIONAL MATRIX FOR THE IMMOBILIZATION OF BIOLOGICAL SUBSTANCES | LEUKOCARE AG (DE) | 2007-11-15 | — | — | WO | disclosed |
| EP-1852443-A1 | Biocompatible three dimensional matrix for the immobilization of biological substances | Leukocare AG (DE) | 2007-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11177446-B2 | Silicon containing organic fluorescent materials | ORAI2, TRPA1, IK | TSHR 4735/4885ACHE 22/4885ESR1 76/4885 |
| US-20190081253-A1 | SILICON CONTAINING ORGANIC FLUORESCENT MATERIALS | ORAI2, TRPA1, IK | TSHR 4735/4885ACHE 22/4885ESR1 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.